Sung JJ et al. |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726384
|
Pazzi P et al. |
Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726385
|
Harris AW et al. |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9726387
|
Bayoumi AM and Redelmeier DA |
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. |
1998 |
AIDS |
pmid:9727572
|
Bermudez LE et al. |
Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice. |
1998 |
J. Infect. Dis. |
pmid:9728568
|
Gorski JC et al. |
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9728893
|
Barzilai A et al. |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. |
1998 |
Scand. J. Infect. Dis. |
pmid:9730300
|
Graham DY et al. |
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection. |
1998 |
Helicobacter |
pmid:9731987
|
Bazzoli F et al. |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. |
1998 |
Helicobacter |
pmid:9731991
|
Lanza FL et al. |
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. |
1998 |
Helicobacter |
pmid:9731994
|
Vakil N et al. |
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. |
1998 |
Am. J. Gastroenterol. |
pmid:9732920
|
Chu KM et al. |
A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. |
1998 |
Am. J. Gastroenterol. |
pmid:9732921
|
Lamouliatte H et al. |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. |
1998 |
Am. J. Gastroenterol. |
pmid:9732938
|
Alder JD et al. |
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9736568
|
Siu LK et al. |
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. |
1998 |
J. Clin. Microbiol. |
pmid:9738066
|
Sevin E et al. |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. |
1998 |
FEMS Microbiol. Lett. |
pmid:9742711
|
Hiratsuka T et al. |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone]. |
1998 |
Nihon Kokyuki Gakkai Zasshi |
pmid:9742869
|
Huang WH et al. |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. |
1998 |
Zhonghua Yi Xue Za Zhi (Taipei) |
pmid:9745160
|
Apseloff G et al. |
Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers. |
1998 |
J Clin Pharmacol |
pmid:9753212
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|